Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

Covid test stocks

Ready to invest in the COVID-19 testing industry? Consider these 9 stocks.

The COVID-19 pandemic triggered massive volatility in the stock market, with increased instability in recent weeks as surging cases have led to a rush of people looking for tests. We've rounded up 9 stocks in companies that produce or sell COVID tests.

The best stocks depend on your portfolio and investment goals. While volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

9 COVID test stocks to watch

We round up a selection of stocks in or related to the COVID-19 testing industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

  1. Abbott Laboratories (ABT)
  2. Quidel Corporation (QDEL)
  3. Cue Health (HLTH)
  4. Lucira Health (LHDX)
  5. Walgreens Boots Alliance (WBA)
  6. CVS Health (CVS)
  7. Agilent Technologies (A)
  8. Hologic (HOLX)
  9. Laboratory Corporation of America (LH)

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in COVID test stocks.
1 - 6 of 6
Name Product Asset types Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Public
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Take a deeper dive into COVID test stocks

If you're interested in investing in the COVID-19 testing industry, take a closer look at what companies in this industry do and how the stocks have historically performed. Keep in mind that positive past performance doesn't guarantee that a stock will continue to rise in the future.

1. Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories stock opened the day at $102.86 after a previous close of $103.38. The latest price was $102.45 (25-minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD45.5 billion and employs 113,000 staff.

  • Market capitalization: $174,281,408,512
  • P/E ratio: 20.7766
  • PEG ratio: 15.7733

Back to top


2. Quidel Corporation (QDEL)

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

Quidel Corporation stock opened the day at $122.34 after a previous close of $121.25. The latest price was $123.00 (25-minute delay). Quidel Corporation is listed on the NASDAQ, has a trailing 12-month revenue of around USD$2.8 billion and employs 6,900 staff.

  • Market capitalization: $4,785,793,536
  • P/E ratio: 3.2329
  • PEG ratio: 7.19

Back to top


3. Cue Health (HLTH)

Cue Health Inc. , a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors.

Cue Health stock opened the day at $9.80 after a previous close of $9.79. The latest price was $9.27 (25-minute delay). Cue Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$683.3 million and employs 1,585 staff.

  • Market capitalization: $472,431,776
  • P/E ratio: 15.2857

Back to top


4. Lucira Health (LHDX)

Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services.

Lucira Health stock opened the day at $6.56 after a previous close of $6.58. The latest price was $8.50 (25-minute delay). Lucira Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$192.7 million and employs 219 staff.

  • Market capitalization: $42,512,888

Back to top


5. Walgreens Boots Alliance (WBA)

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International.

Walgreens Boots Alliance stock opened the day at $33.10 after a previous close of $33.16. The latest price was $32.25 (25-minute delay). Walgreens Boots Alliance is listed on the NASDAQ, has a trailing 12-month revenue of around USD$134.5 billion and employs 315,000 staff.

  • Market capitalization: $28,624,191,488
  • P/E ratio: 5.6136
  • PEG ratio: 12.0008

Back to top


6. CVS Health (CVS)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

CVS Health stock opened the day at $99.99 after a previous close of $100.45. The latest price was $98.58 (25-minute delay). CVS Health is listed on the NYSE, has a trailing 12-month revenue of around USD$306.9 billion and employs 216,000 staff.

  • Market capitalization: $125,204,594,688
  • P/E ratio: 15.5326
  • PEG ratio: 1.2901

Back to top


7. Agilent Technologies (A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Agilent Technologies stock opened the day at $132.30 after a previous close of $132.64. The latest price was $132.18 (25-minute delay). Agilent Technologies is listed on the NYSE, has a trailing 12-month revenue of around USD$6.7 billion and employs 17,700 staff.

  • Market capitalization: $35,983,781,888
  • P/E ratio: 27.7511
  • PEG ratio: 1.9885

Back to top


8. Hologic (HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.

Hologic stock opened the day at $76.48 after a previous close of $76.62. The latest price was $76.56 (25-minute delay). Hologic is listed on the NASDAQ, has a trailing 12-month revenue of around USD$5.2 billion and employs 6,705 staff.

  • Market capitalization: $16,107,610,112
  • P/E ratio: 10.9542
  • PEG ratio: 0.9333

Back to top


9. Laboratory Corporation of America (LH)

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Laboratory Corporation of America stock opened the day at $313.24 after a previous close of $313.34. The latest price was $314.21 (25-minute delay). Laboratory Corporation of America is listed on the NYSE, has a trailing 12-month revenue of around USD$15.7 billion and employs 75,000 staff.

  • Market capitalization: $19,146,721,280
  • P/E ratio: 10.1243
  • PEG ratio: 2.0682

Back to top

How to buy COVID test stocks

Sign up with an online broker or platform to invest in one or more of these COVID test stocks.

  1. Compare share trading platforms. Use our comparison table to narrow down top brokers by fees and bonuses.
  2. Open and fund your brokerage account. You’ll need personal and financial details, like your contact and bank information.
  3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like ABT or CVS.
  4. Decide on how many to buy. Some brokers will allow you to purchase fractional shares, while others require you to purchase whole shares.
  5. Choose an order type. Invest in the COVID test stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price.
  6. Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the COVID-19 testing industry, track how your stock performs to decide when it’s time to sell.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Bottom line

While it’s possible to turn a profit investing in COVID test stocks, keep in mind that — like any investment — COVID test stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the COVID-19 testing industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site